Near Infrared Imaging Market Value to Surge from US$ 1,338.6 Mn in 2025 to US$ 2,571.1 Mn by 2032, Says Persistence Market Research

The near infrared (NIR) imaging market is experiencing rapid growth, fueled by its increasing adoption in medical diagnostics, particularly in oncology, cardiology, and neurology. Near infrared imaging has proven to be a groundbreaking technology that provides high-precision, real-time imaging of biological tissues, allowing clinicians to visualize blood flow, tissue oxygenation, and even tumors. This capability has made it particularly useful in minimally invasive surgeries, helping surgeons navigate complex procedures with heightened accuracy. As of 2025, the global NIR imaging market is valued at approximately US$ 1,338.6 million, with projections suggesting it will expand to US$ 2,571.1 million by 2032, growing at a compound annual growth rate (CAGR) of 9.8% over the period.

The demand for NIR imaging is driven by several key factors, including the growing incidence of cancer, cardiovascular diseases (CVDs), and neurological disorders, all of which require sophisticated imaging for early detection and treatment. In addition, the integration of artificial intelligence (AI) into imaging systems is enhancing diagnostic accuracy, reducing recovery times, and improving patient outcomes. NIR imaging is used in over 4.5 million treatments annually worldwide, with a success rate exceeding 92%. Among the different segments of the market, the reagents and consumables segment, especially the use of indocyanine green (ICG), is expected to dominate due to its superior performance compared to traditional dyes. Regionally, North America is expected to lead the market, primarily driven by advanced healthcare infrastructure, substantial investments in medical research, and a high adoption rate of NIR imaging technologies.

Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/35177

Key Highlights from the Report

• The near infrared imaging market is projected to grow from US$ 1,338.6 million in 2025 to US$ 2,571.1 million by 2032, representing a CAGR of 9.8%.
• North America will dominate the global market, accounting for 39.1% of the market share in 2025, with a CAGR of 8.5%.
• The reagents and consumables segment is expected to contribute 57.5% of the market revenue in 2025.
• Hospitals are expected to be the leading end-users, accounting for 47.3% of the market share in 2025.
• Advanced fluorescence-guided surgeries are improving surgical outcomes, with a 30% improvement in tumor removal accuracy.
• The increasing integration of AI and fluorescence imaging is driving the precision and efficiency of diagnostic procedures.

Market Segmentation
Product Type

The near infrared imaging market can be segmented by product type into reagents and consumables, imaging systems, and others. The reagents and consumables segment, which includes fluorescent dyes and contrast agents such as indocyanine green (ICG), is expected to dominate the market due to its higher sensitivity compared to visible-light-based dyes. These agents are increasingly being used for real-time visualization in surgeries, such as in vascular, oncological, and neurological procedures. Imaging systems, on the other hand, include NIR devices that capture and process images for various applications. The rise in the number of minimally invasive surgeries and the demand for real-time diagnostic tools are driving the growth of these imaging systems. Other products include software tools used for image processing and AI-enhanced imaging systems.

End-User Insights

The end-users of NIR imaging technology include hospitals, diagnostic centers, research institutes, and clinics. Among these, hospitals are expected to lead the market, accounting for 47.3% of the market share in 2025. The increasing adoption of minimally invasive surgical procedures in hospitals, driven by the need for enhanced diagnostic accuracy and reduced patient recovery time, is a key factor contributing to this dominance. Hospitals are also primary centers for cancer detection, cardiovascular interventions, and neurosurgery, all of which benefit significantly from the precision offered by NIR imaging.

Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/near-infrared-imaging-market.asp

Regional Insights

The regional distribution of the NIR imaging market reveals significant trends and opportunities for growth in different geographical areas. North America is projected to hold the largest share of the market, driven by significant investments in healthcare infrastructure, R&D, and early adoption of advanced medical technologies. The United States, in particular, is a hub for research in optical imaging and fluorescence-guided surgery, with major healthcare institutions and universities driving the demand. Europe is also witnessing considerable growth, with a focus on enhancing minimally invasive procedures and improving surgical outcomes in oncology and cardiology. The Asia Pacific region, with its large and growing patient pool, especially in countries like China, India, and Japan, is expected to witness rapid adoption of NIR imaging technologies. The demand in this region is also fueled by the increasing prevalence of age-related conditions, such as cancer and cardiovascular diseases, along with the expansion of healthcare access.

Market Drivers

The near infrared imaging market is witnessing several significant drivers that contribute to its expansion. A primary factor is the increasing incidence of cancer and cardiovascular diseases (CVDs). According to recent statistics, over 19 million new cancer cases are diagnosed globally each year, with many of these patients undergoing surgeries where NIR imaging can significantly enhance tumor detection and surgical precision. Similarly, CVDs cause millions of deaths annually, and NIR imaging is playing an important role in vascular surgeries, helping reduce complications and improve patient outcomes. The demand for minimally invasive surgeries (MIS) is another key driver. MIS procedures have grown rapidly over the past decade, thanks to the reduced recovery time and smaller incisions compared to traditional surgery. NIR imaging offers superior visualization during these procedures, contributing to their widespread adoption.

Another factor propelling the growth of the NIR imaging market is the rise in AI-integrated imaging systems. The use of AI in imaging has greatly improved the precision of diagnostics, offering real-time data analysis and facilitating faster decision-making in clinical settings. AI-based systems are particularly useful in oncology and neurology, where early detection of tumors and brain abnormalities is crucial. Additionally, the growing adoption of point-of-care diagnostics and telemedicine is enhancing the use of NIR imaging outside traditional hospital settings, opening new opportunities for the technology to penetrate a broader range of healthcare applications.

Market Restraints

Despite its rapid growth, the NIR imaging market faces several restraints, primarily related to cost. NIR imaging systems are expensive, with prices ranging from US$ 30,000 to US$ 150,000 for basic systems, and up to US$ 250,000 for more advanced, cooled detector models. These high costs limit the widespread adoption of NIR imaging, particularly in developing countries and smaller healthcare facilities with limited budgets. Furthermore, the maintenance costs of NIR imaging systems can add an additional 15%-20% to the total cost of ownership annually. Specialized training is also required for the proper operation of NIR systems, which adds another layer of complexity and cost. These financial constraints are slowing down the adoption of NIR imaging in certain regions, particularly in low-income countries.

Market Opportunities

The NIR imaging market holds numerous opportunities, particularly in research and development for targeted molecular imaging. Molecular imaging allows for the visualization of biological processes at the cellular level, which is a major advancement in early disease detection and treatment planning. The development of targeted contrast agents, such as fluorescent nanoparticles and indocyanine green, is opening up new applications in cancer diagnostics, cardiovascular disease, and neurodegenerative disorders. For example, advancements in NIR fluorophores have enabled a 30% improvement in the accuracy of tumor margin detection during cancer surgeries.

Additionally, the integration of NIR imaging into portable and handheld devices for point-of-care diagnostics represents a significant opportunity for growth. These devices are being increasingly used in monitoring patients' oxygen levels, wound healing, and metabolic conditions. The rise of telemedicine is also opening up new avenues for the use of NIR imaging in remote patient monitoring and diagnostics, which is especially important in regions with limited access to healthcare.

Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/35177

Company Insights

Several major players dominate the NIR imaging market, with strong R&D investments and product innovations helping them maintain a competitive edge. Some of the leading companies include:

• Leica Microsystems
• Medtronic (Visionsense)
• PerkinElmer Inc.
• Zeiss Group
• FLUOPTICS SAS (Getinge)
• Stryker
• KARL STORZ SE & Co. KG
• Olympus
• Hamamatsu Photonics K.K.
• Mizuho Medical Co., Ltd.
• Shimadzu Corporation
• Headwall Photonics
• Koninklijke Philips N.V.
• Hitachi, Ltd.
• Bruker
• GE Healthcare
• FUJIFILM Holdings Corporation
• LI-COR Biotech, LLC
• Nikon Instruments Inc.
• Agilent Technologies, Inc.

Near Infrared Imaging Market Segmentation

By Product

Devices
Near-infrared Fluorescence Imaging Systems
Near-infrared Fluorescence & Bioluminescence Imaging Systems
Reagents & Consumables

By Procedure

Oncology Surgeries
Plastic/ Reconstructive Surgeries
OB/GYN Surgeries
Cardiovascular Surgeries
Gastrointestinal Surgeries
Others

By Application

Clinical
Preclinical
Medical

By End User

Hospitals
Specialty Centers
Biotech and Pharma Companies
Academic & Research Institutes
Others

By Region

North America
Europe
East Asia
South Asia and Oceania
Middle East and Africa
Latin America

Recent Developments:

December 2024: Scientists at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) in India developed flexible NIR plasmonic devices aimed at revolutionizing wearable sensors and medical imaging tools.

November 2024: Irillic Private Ltd. introduced India's first True 4K NIR Laparoscopic Imaging System, enhancing real-time ICG fluorescence quantification and remote access.

Conclusion

The near infrared imaging market is poised for significant growth, driven by advancements in medical imaging technologies, the rising prevalence of diseases such as cancer and cardiovascular diseases, and increasing demand for minimally invasive procedures. As healthcare continues to embrace precision medicine and AI-driven diagnostics, NIR imaging will play an increasingly important role in improving patient outcomes and surgical success rates. While the market faces challenges such

Read More Related Reports:

Therapeutic Apheresis Market https://www.persistencemarketresearch.com/market-research/therapeutic-apheresis-market.asp
Cough Suppressant Market https://www.persistencemarketresearch.com/market-research/cough-suppressant-market.asp
Intracranial Aneurysm Market https://www.persistencemarketresearch.com/market-research/intracranial-aneurysm-market.asp
Non-injectable Insulin Market https://www.persistencemarketresearch.com/market-research/non-injectable-insulin-market.asp

Contact Us:

Persistence Market Research
Second Floor, 150 Fleet Street, London, EC4A 2DQ, United Kingdom
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.